Search Results - "Miglarese, M." :: K.UTB vyhledávací portál | TBU Library Retrieval Portal

Poly-Ligand Profiling differentiates pancreatic cancer patients according to treatment benefit from gemcitabine+placebo versus gemcitabine+evofosfamide and identifies candidate targets

Poly-Ligand Profiling differentiates pancreatic cancer patients according to treatment benefit from gemcitabine+placebo versus gemcitabine+evofosfamide and identifies candidate targets

by Domenyuk, V., Liu, X., Magee, D., Gatalica, Z., Stark, A., Kennedy, P., Rosenow, M., Barker, A., Berry, D., Poste, G., Halbert, D., Hart, C., Famulok, M., Mayer, G., Korn, M., Miglarese, M., Spetzler, D.
Published in Annals of oncology (01.06.2018)

Get full text

Journal Article

OR13,78 Compensatory activation of insulin receptor (IR) upon inhibition of insulin-like growth factor-1 receptor (IGF-1R): Rationale for co-targeting IGF-1R and IR in cancer

OR13,78 Compensatory activation of insulin receptor (IR) upon inhibition of insulin-like growth factor-1 receptor (IGF-1R): Rationale for co-targeting IGF-1R and IR in cancer

by Buck, E, Gokhale, P, Koujak, S, Brown, E, Tao, N, Rosenfeld-Franklin, M, Lerner, L, Wild, R, Epstein, D, Pachter, J, Miglarese, M
Published in Growth hormone & IGF research (2010)

Get full text

Journal Article

Melanomas, from the cell cycle point of view (Review)

Melanomas, from the cell cycle point of view (Review)

by Halaban, R, Miglarese, M R, Smicun, Y, Puig, S
Published in International journal of molecular medicine (01.02.1998)

Get more information

Journal Article

Modulation of c-Myb-Induced Transcription Activation by a Phosphorylation Site Near the Negative Regulatory Domain

Modulation of c-Myb-Induced Transcription Activation by a Phosphorylation Site Near the Negative Regulatory Domain

by Aziz, N, Miglarese, M R, Hendrickson, R C, Shabanowitz, J, Sturgill, T W, Hunt, D F, Bender, T P
Published in Proceedings of the National Academy of Sciences - PNAS (03.07.1995)

Get full text

Journal Article

325 POSTER Erlotinib, an EGFR kinase inhibitor, sensitizes mesenchymal-like tumor cells to the actions of OXA-01, a selective non-macrolide inhibitor of mTORC1/mTORC2

325 POSTER Erlotinib, an EGFR kinase inhibitor, sensitizes mesenchymal-like tumor cells to the actions of OXA-01, a selective non-macrolide inhibitor of mTORC1/mTORC2

by Barr, S, Russo, S, Bhagwat, S, Crew, A, Iwata, K, Epstein, D, Pachter, J, Miglarese, M
Published in European journal of cancer supplements (2008)

Get full text

Journal Article

The protein tyrosine kinase substrate cortactin is differentially expressed in murine B lymphoid tumors

The protein tyrosine kinase substrate cortactin is differentially expressed in murine B lymphoid tumors

by Miglarese, M R, Mannion-Henderson, J, Wu, H, Parsons, J T, Bender, T P
Published in Oncogene (01.07.1994)

Get more information

Journal Article

Abstract P4-12-08: Use of an aptamer library based next generation omics platform for the development of a novel trastuzumab predictive assay

Abstract P4-12-08: Use of an aptamer library based next generation omics platform for the development of a novel trastuzumab predictive assay

by Spetzler, D, Domenyuk, V, Santhanam, R, Wei, X, Stark, A, Wang, J, Gatalica, Z, Miglarese, M, Vidal, G, Schwartzberg, LS
Published in Cancer research (Chicago, Ill.) (15.02.2017)

Get full text

Journal Article

P-132Poly-Ligand Profiling differentiates pancreatic cancer patients according to treatment benefit from gemcitabine+placebo versus gemcitabine+evofosfamide and identifies candidate targets

P-132Poly-Ligand Profiling differentiates pancreatic cancer patients according to treatment benefit from gemcitabine+placebo versus gemcitabine+evofosfamide and identifies candidate targets

by Domenyuk, V, Liu, X, Magee, D, Gatalica, Z, Stark, A, Kennedy, P, Rosenow, M, Barker, A, Berry, D, Poste, G, Halbert, D, Hart, C, Famulok, M, Mayer, G, Korn, M, Miglarese, M, Spetzler, D
Published in Annals of oncology (01.06.2018)

Get full text

Journal Article

Differential Regulation of c-Myb-induced Transcription Activation by a Phosphorylation Site in the Negative Regulatory Domain

Differential Regulation of c-Myb-induced Transcription Activation by a Phosphorylation Site in the Negative Regulatory Domain

by Miglarese, M R, Richardson, A F, Aziz, N, Bender, T P
Published in The Journal of biological chemistry (13.09.1996)

Get full text

Journal Article

Abstract P5-08-03: Poly-ligand profiling and target identification from formalin-fixed-paraffin embedded HER2+ breast cancer specimens

Abstract P5-08-03: Poly-ligand profiling and target identification from formalin-fixed-paraffin embedded HER2+ breast cancer specimens

by O'Neill, HA, Tinder, TT, Maher, V, Rosenow, M, Richards, M, Santhanam, R, Wei, X, Domenyuk, V, Miglarese, MR, Spetzler, D
Published in Cancer research (Chicago, Ill.) (15.02.2018)

Get full text

Journal Article

Regulation of fibroblast growth factor 2 expression in melanoma cells by the c-MYB proto-oncoprotein

Regulation of fibroblast growth factor 2 expression in melanoma cells by the c-MYB proto-oncoprotein

by MIGLARESE, M. R, HALABAN, R, GIBSON, N. W
Published in Cell growth & differentiation (01.11.1997)

Get full text

Journal Article

ARRY-649, a member of a novel class of Eg5 kinesin inhibitors

ARRY-649, a member of a novel class of Eg5 kinesin inhibitors

by Miglarese, M. R., Wallace, E., Woessner, R., Allen, S., Hans, J., Lemieux, C., Dewolf, W., Lyssikatos, J., Lee, P., Koch, K.
Published in Journal of clinical oncology (20.06.2006)

Get full text

Journal Article

Abstract P2-01-08: Adaptive dynamic artificial poly-ligand targeting: Aptamer-based profiling of liquid biopsies to improve the accuracy of breast cancer diagnoses in women with dense breast tissue

Abstract P2-01-08: Adaptive dynamic artificial poly-ligand targeting: Aptamer-based profiling of liquid biopsies to improve the accuracy of breast cancer diagnoses in women with dense breast tissue

by Domenyuk, V, Zhong, Z, Wang, J, Stark, A, Chen, W, Xiao, N, Miglarese, MR, Famulok, M, Mayer, G, Spetzler, DB
Published in Cancer research (Chicago, Ill.) (15.02.2016)

Get full text

Journal Article

Abstract P2-09-09: Polyligand profiling differentiates cancer patients according to their benefit of treatment

Abstract P2-09-09: Polyligand profiling differentiates cancer patients according to their benefit of treatment

by Domenyuk, V, Gatalica, Z, Santhanam, R, Wei, X, Stark, A, Kennedy, P, Toussaint, B, Levenberg, S, Wang, R, Xiao, N, Greil, R, Rinnerthaler, G, Gampenrieder, S, Heimberger, AB, Berry, DJ, Barker, A, Demetri, GD, Quackenbush, J, Marshall, JL, Poste, G, Vacirca, JL, Vidal, GA, Schwartzberg, LS, Halbert, DD, Voss, A, Miglarese, MR, Famulok, M, Mayer, G, Spetzler, D
Published in Cancer research (Chicago, Ill.) (15.02.2018)

Get full text

Journal Article

Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1

Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1

by Halaban, R, Cheng, E, Zhang, Y, Mandigo, C E, Miglarese, M R
Published in Oncogene (14.05.1998)

Get full text

Journal Article

Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1 sub(E132), but not by deletion of p16 super(INK4A) or p21 super(WAF1/CIP1)

Release of cell cycle constraints in mouse melanocytes by overexpressed mutant E2F1 sub(E132), but not by deletion of p16 super(INK4A) or p21 super(WAF1/CIP1)

by Halaban, R, Cheng, E, Zhang, Y, Mandigo, CE, Miglarese, M R
Published in Oncogene (01.05.1998)

Get full text

Journal Article

Release of cell cycle constraints in mouse melanocytes by overexgressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1

Release of cell cycle constraints in mouse melanocytes by overexgressed mutant E2F1E132, but not by deletion of p16INK4A or p21WAF1/CIP1

by HALABAN, R, CHENG, E, ZHANG, Y, MANDIGO, C. E, MIGLARESE, M. R
Published in Oncogene (1998)

Get full text

Journal Article